These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 17551398)

  • 1. A pre-HAART follow-up study of the hematologic manifestations in children with perinatal HIV-1 infection: suggestions for reclassification of clinical staging.
    Consolini R; Bencivelli W; Legitimo A; Galli L; Tovo P; Gabiano C; De Martino M;
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):376-83. PubMed ID: 17551398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.
    Chiappini E; Galli L; Tovo PA; Gabiano C; Lisi C; Gattinara GC; Esposito S; Viganò A; Giaquinto C; Rosso R; Guarino A; de Martino M
    AIDS; 2007 Jul; 21(12):1607-15. PubMed ID: 17630556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer rates after year 2000 significantly decrease in children with perinatal HIV infection: a study by the Italian Register for HIV Infection in Children.
    Chiappini E; Galli L; Tovo PA; Gabiano C; Lisi C; Giaquinto C; Rampon O; Gattinara GC; De Marco G; Osimani P; Manzionna M; Miniaci A; Pintor C; Rosso R; Esposito S; Viganò A; Dodi I; Maccabruni A; Fundarò C; de Martino M;
    J Clin Oncol; 2007 Jan; 25(1):97-101. PubMed ID: 17194910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project.
    Barnhart HX; Caldwell MB; Thomas P; Mascola L; Ortiz I; Hsu HW; Schulte J; Parrott R; Maldonado Y; Byers R
    Pediatrics; 1996 May; 97(5):710-6. PubMed ID: 8628612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologic manifestations of infection with the human immunodeficiency virus.
    Balea M
    Rom J Intern Med; 1994; 32(2):87-118. PubMed ID: 7920333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The hematological manifestations in human immunodeficiency virus (HIV) infection in children].
    Dragomir D; Popescu V
    Pediatrie (Bucur); 1992; 41(4):44-9. PubMed ID: 1335773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of human immunodeficiency virus-infected and -exposed children undergoing surgery--a prospective study.
    Karpelowsky JS; Leva E; Kelley B; Numanoglu A; Rode H; Millar AJ
    J Pediatr Surg; 2009 Apr; 44(4):681-7. PubMed ID: 19361626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
    An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of human immunodeficiency virus (HIV) type 1 load, CD4 T cell level, and clinical class as time-fixed and time-varying markers of disease progression in HIV-1-infected children.
    Kalish LA; McIntosh K; Read JS; Diaz C; Landesman SH; Pitt J; Rich KC; Shearer WT; Davenny K; Lew JF
    J Infect Dis; 1999 Nov; 180(5):1514-20. PubMed ID: 10515810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
    Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
    J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
    Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
    Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
    Guillén S; García San Miguel L; Resino S; Bellón JM; González I; Jiménez de Ory S; Muñoz-Fernández MA; Navarro ML; Gurbindo MD; de José MI; Mellado MJ; Martín-Fontelos P; Gonzalez-Tomé MI; Martinez J; Beceiro J; Roa MA; Ramos JT;
    HIV Med; 2010 Apr; 11(4):245-52. PubMed ID: 20050937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic complications of HIV infection.
    Sloand E
    AIDS Rev; 2005; 7(4):187-96. PubMed ID: 16425959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic value of plasma triglycerides in human immunodeficiency virus infection].
    Rovira E; Belda A; Martínez MD; Gonzalvo F; Pascual JM; Redón J
    Rev Clin Esp; 1995 Jul; 195(7):455-8. PubMed ID: 7667519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor.
    Ellaurie M; Burns ER; Rubinstein A
    Am J Pediatr Hematol Oncol; 1990; 12(4):449-53. PubMed ID: 2285125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.